Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Exagen Inc (NASDAQ: XGN) closed at $3.29 up 0.61% from its previous closing price of $3.27. In other words, the price has increased by $0.61 from its previous closing price. On the day, 80710.0 shares were traded. XGN stock price reached its highest trading level at $3.4 during the session, while it also had its lowest trading level at $3.2.
Ratios:
For a deeper understanding of Exagen Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.72 and its Current Ratio is at 4.05. In the meantime, Its Debt-to-Equity ratio is 1.83 whereas as Long-Term Debt/Eq ratio is at 1.69.
On April 15, 2021, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $25.Canaccord Genuity initiated its Buy rating on April 15, 2021, with a $25 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 20 ’24 when NMSIC Co-Investment Fund, L.P. sold 200,000 shares for $3.30 per share. The transaction valued at 660,040 led to the insider holds 2,108,958 shares of the business.
Black Jeffrey G. bought 22,298 shares of XGN for $66,448 on Nov 15 ’24. The Chief Financial Officer now owns 274,492 shares after completing the transaction at $2.98 per share. On Nov 14 ’24, another insider, ABALLI JOHN, who serves as the President and CEO of the company, bought 24,305 shares for $2.81 each. As a result, the insider paid 68,297 and bolstered with 689,799 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XGN now has a Market Capitalization of 58026716 and an Enterprise Value of 47429568. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.04 while its Price-to-Book (P/B) ratio in mrq is 4.48. Its current Enterprise Value per Revenue stands at 0.837 whereas that against EBITDA is -3.435.
Stock Price History:
The Beta on a monthly basis for XGN is 1.42, which has changed by 0.62068963 over the last 52 weeks, in comparison to a change of 0.23806548 over the same period for the S&P500. Over the past 52 weeks, XGN has reached a high of $6.22, while it has fallen to a 52-week low of $1.30. The 50-Day Moving Average of the stock is -15.24%, while the 200-Day Moving Average is calculated to be 25.15%.
Shares Statistics:
For the past three months, XGN has traded an average of 112.76K shares per day and 214440 over the past ten days. A total of 17.52M shares are outstanding, with a floating share count of 8.80M. Insiders hold about 50.12% of the company’s shares, while institutions hold 36.26% stake in the company. Shares short for XGN as of 1730332800 were 52214 with a Short Ratio of 0.69, compared to 1727654400 on 15746. Therefore, it implies a Short% of Shares Outstanding of 52214 and a Short% of Float of 0.44999999999999996.
